LD-2 disclosure · 1st Quarter - Report
ASTCT
Client
- Name
- ASTCT
- Description
- Healthcare Society
- Location
- District of Columbia · United States of America
Registrant
- Description
- Trade association
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act
LobbyistsMOLLY FORD
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS) · Natl Institutes of Health (NIH)
Medicare/Medicaid
- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act
LobbyistsMOLLY FORD
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Medical/Disease Research/Clinical Labs
- Labor-HHS Appropriations - CAR-T Therapy clarification
